Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI)

Traumatic Brain Injury Clinical Trial

— SAA-TBI  

Official title:

Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03277859
• Other study ID #: 17-0785
• Status: Completed
• Phase: N/A
• Start date: August 16, 2017
• Est. completion date: June 30, 2019

Study information

• Verified date: July 2019
• Source: VA Eastern Colorado Health Care System
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The specific aims of the proposed study are to evaluate: 1) the feasibility of design elements of a Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI) intervention trial (e.g., an exercise run-in to facilitate participant retention); 2) yoga instructor fidelity; and 3) variability estimates for candidate proximal and distal outcomes. Performance of validated measures, including those associated with quality of life, as well as data collected via ecological momentary assessment and pedometry (physical activity) will be evaluated.

Description:

A signature injury being sustained by Veterans from recent conflicts is mild traumatic brain injury (mTBI). For some, this condition is associated with multiple disabling post-concussive symptoms, including post-concussive headaches (PCH). PCHs are notoriously resistant to medication alone, and are associated with increased muscle tension, avoidance of physical activities, and anxiety related to having chronic pain. In this study, the feasibility (ease of implementation) of the design elements of an interventional trial of Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI) will be explored. Yoga is operationalized as a practice involving physical postures, breath awareness, breathing exercises and mindfulness meditation. It is conceptualized as having three "active ingredients" (i.e., regulation of the autonomic nervous system via physical activity/breathing exercises, release of muscular tension associated with headaches, and mindfulness/acceptance). The specific aims of the proposed study are to evaluate: 1) the feasibility of design elements of an SAA-TBI intervention trial (e.g., an exercise run-in to facilitate participant retention); 2) yoga instructor fidelity; and 3) variability estimates for candidate proximal and distal outcomes. Performance of validated measures, including those associated with quality of life, as well as data collected via ecological momentary assessment and pedometry (physical activity) will be evaluated. Project aims will be evaluated using an experimental design where participants will be block randomized in a stratified manner to SAA-TBI or a waitlist using a 1:1 ratio. The waitlist group will initially receive 8 weeks of enhanced treatment as usual (ETU). The participants in the waitlist condition will be offered SAA-TBI, after the initial group has completed the intervention. Both groups of participants will complete multiple measures at baseline and after the conclusion of the intervention. Maintenance among the intervention group will also be explored. Participants will be asked to complete daily homework documenting their headaches and yoga practice outside of class, and be provided with multiple modalities (web-based, mobile app, text, or paper and pencil) by which this can be accomplished. In specific, the proposed study will evaluate the feasibility of the trial design for an accessible, non-pharmacological, yoga-based intervention for chronic PCH pain among Veterans with mTBI, with the long-term goal of informing future efficacy trials.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: June 30, 2019
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• Between the ages of 18 and 55

• Able to provide informed consent

• History of mTBI per the Ohio State University TBI-ID (OSU-TBI-ID)

• History of PCH pain (TTH, migraine, or mixed), with onset of pain or increase in previous headache pain having occurred within one month of mTBI as determined by structured examination using criteria outlined in the International Classification of Headache Disorders-3 beta (ICHD-3 beta)

• Duration of PCH pain being greater than one year as determined by structured medical examination

• Score of >49 on the Headache Impact Test-6 (HIT-6)

• Medical clearance by study provider to participate in yoga protocol

Exclusion Criteria:

• Younger than 18, or older than 55 years of age

• Active substance dependence, excluding Cannabis dependence (based on local issues regarding the legality of cannabis), as determined by structured clinical interview

• Moderate to severe TBI as determined per the OSU-TBI-ID

• Identification of active psychosis as determined by structured clinical interview

• Failing to receive medical clearance by study provider;

• Inability to participate in the manualized intervention without postures being significantly modified

• Already participating in an ongoing consistent yoga practice (two or more times weekly)

• Involvement in another research interventional trial aimed at addressing pain-related symptoms.

Related Conditions & MeSH terms

• Brain Injuries
• Brain Injuries, Traumatic
• Headache
• Post-concussive Headaches
• Traumatic Brain Injury

Intervention

Behavioral:
• SAA-TBI
Yoga twice a week for 75 minutes for 8 weeks

Locations

Country	Name	City	State
United States	Rocky Mountain Regional VA Medical Center	Aurora	Colorado

Sponsors (2)

Lead Sponsor	Collaborator
VA Eastern Colorado Health Care System	University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Headaches per week	Headache Tracking Form (HTF) will query about daily headache frequency, duration, severity, and treatment per event.	Change from baseline to approximately 20 weeks